# PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)

> **NCT05419193** · PHASE2,PHASE3 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 168 (actual)

## Conditions studied

- Stroke
- Vascular Accident
- Intracranial Hemorrhages
- Intracerebral Hemorrhage
- Hemorrhagic Stroke
- Stroke, Acute

## Interventions

- **DRUG:** Propranolol Hydrochloride
- **OTHER:** control group

## Key facts

- **NCT ID:** NCT05419193
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-21
- **Primary completion:** 2024-12-18
- **Final completion:** 2025-03-11
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419193, "PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05419193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*